MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR
ABELA, Alexander Russell,ALCACIO, Timothy,ANDERSON, Corey,BAEK, Minson,BUSCH, Brett Bradley,CLEVELAND, Thomas,FRIEMAN, Bryan A.,GROOTENHUIS, Peter,HADIDA RUAH, Sara Sabina,HUGHES, Robert M.,JOSHI, Pra
申请号：
TN2019000079
公开号：
TN2019000079A1
申请日:
2017.09.29
申请国别(地区):
TN
年份:
2020
代理人:
摘要：
Compounds of Formula (I), pharmaceutically acceptable salts thereof, deuterated derivatives of any of the foregoing, and metabolites of any of the foregoing are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.
